首页> 外国专利> The controlled release cell consists of a central component containing R-Lansoprazol and a soluble controlled release coating, depending on the copolymer pH and L (Div. Sol) selected from the metabolic acid. 2051-2003).

The controlled release cell consists of a central component containing R-Lansoprazol and a soluble controlled release coating, depending on the copolymer pH and L (Div. Sol) selected from the metabolic acid. 2051-2003).

机译:控释池由包含R-兰索拉唑和可溶性控释包衣的中心成分组成,具体取决于从代谢酸中选择的共聚物pH和L(Div。Sol)。 2051-2003)。

摘要

Tablet, granule or pellet Fine controlled release which includes a Central Particle containing lansoprazole or a derivative thereof,And a layer of coating controlled release soluble pH dependent comprising at least one class of polymeric Substances (Div. Sun. No. 2051 - 03).
机译:片剂,颗粒剂或丸剂精细控制释放,包括含有兰索拉唑或其衍生物的中央颗粒,以及取决于包衣的控制释放的可溶性pH依赖层,其包含至少一类聚合物质(Div。Sun. 2051-03)。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号